“Prospective Observational Study to Assess Effectiveness and Safety of Intravenous Ferric Carboxymaltose 1000 Mg in Patients of Chronic Heart Failure With Iron DeficiEncy - PRIDE-HF Study”. Cardiology and Cardiovascular Medicine 7, no. 6 (December 5, 2023): 349–354. Accessed September 17, 2026. https://fortunejournals.org/ojs/index.php/ccm/article/view/16439.